Steven Lang, PhDVice President, Biologics at Aragen Bioscience
Steven Lang is responsible for Aragen's bioproduction, cell line development and analytical groups. He was earlier with Genentech's cell culture department as a director, overseeing research material generation, cell line development, automation and CHO process development, covering activities from DNA to Phase II clinical supplies. In addition to his functional role, Steven led an initiative to modernize the CMC scientific data management processes, which spawned numerous digitization efforts across the global Roche Technical Development network to drive efficiency, transparency and compliance. He also acted as CMC leader for a project team delivering an innovative bispecific antibody into clinical trials. Prior to Genentech, he was with Janssen and Johnson & Johnson.